跳至主要内容
临床试验/NL-OMON27093
NL-OMON27093招募中不适用

BENEFIT: Belgium and the Netherlands Idiopathic Pulmonary Fibrosis and Infliximab Trial

Investigator's initiated study performed by BENEFIT study group0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
18

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diagnosis of IPF(2):
  • a) If possible a thoracoscopic or open lung biopsy showing UIP. A thoracoscopic or open lung biopsy must be performed in patients <51 years old. Transbronchial biopsy is strongly advocated and should show no features to support an alternate diagnosis.

排除标准

  • 1. Critical low lung function: FVC < 50%.
  • 2. Artificially ventilated.

研究者

发起方
Investigator's initiated study performed by BENEFIT study group

相似试验

招募中
不适用
Dutch BifUrcaTion Study Evaluating CHaracteristics of the Side Branch Opening with Optical Coherence Tomography after Side Branch FENestration in Patients Treated with COMBO or Xience Stent.
NL-OMON48918Academisch Medisch Centrum30
尚未招募
不适用
Dutch BifUrcaTion Study Evaluating CHaracteristics of the Side Branch OPening with Optical Coherence Tomography after Side Branch FENestration in Patients Treated with COMBO or XIENCE Stent.Coronary Artery Disease
NL-OMON25824Orbus Neich30
招募中
3 期
BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of the Global Ballad pooled data analysis.
2024-518349-85-01Groupe Belge D'Oncologie Digestive30
进行中(未招募)
不适用
A phase I/II multicentric Belgian prospective novel sequential chemo-immunotherapy regimen for adjuvant treatment in non-muscle invasive bladder cancer. - Novel chemo-immunotherapy for non-muscle invasive bladder cancer
EUCTR2011-000607-41-BECentre Hospitalier de Jolimont-Lobbes-Tubize-Nivelles
尚未招募
不适用
DWELL, a 12-week self-management support programme to improve blood glucose levels, quality of life and overall wellbeing.NIDDMMODYType 2 Diabetes MellitusMESH terms: Diabetes Mellitus, Adult-OnsetDiabetes Mellitus, Ketosis-ResistantDiabetes Mellitus, Maturity-OnsetDiabetes Mellitus, Non Insulin DependentDiabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus, Noninsulin DependentDiabetes Mellitus, Noninsulin-DependentDiabetes Mellitus, Slow-OnsetDiabetes Mellitus, StableDiabetes Mellitus, Type IIMaturity-Onset DiabetesMaturity-Onset Diabetes MellitusNoninsulin-Dependent Diabetes MellitusType 2 Diabetes MellitusKeywords: DiabetesQuality of LifeMotivational InterviewingActivity TrackingType 2 Diabetes
NL-OMON23619Maarten Gijssel, Kinetic AnalysisPastoor Pottersplein 654815 BB BredaE: info@kinetic-analysis.com270